X4 Pharmaceuticals Stock Forward View
| XFOR Stock | USD 4.09 0.27 7.07% |
X4 Pharmaceuticals's Naive Prediction reference data reflects the model's output when applied to available daily price observations. This page summarizes the model output and key accuracy metrics for reference. The projected value and error metrics are calculated from available daily price observations. This information is intended as reference material for analytical purposes.
The Naive Prediction forecasted value of X4 Pharmaceuticals on the next trading day is expected to be 3.68 with a mean absolute deviation of 0.15 and the sum of the absolute errors of 9.16.This model is not at all useful as a medium-long range forecasting tool of X4 Pharmaceuticals. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict X4 Pharmaceuticals. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights. The Naive Prediction reference values for X4 Pharmaceuticals are derived from publicly available price data and should be used for informational purposes only. X4 Pharmaceuticals Cash Forecast
The forecast of X4 Pharmaceuticals' future cash flows is built on systematic analysis of historical financial statements. Recurring patterns in X4 Pharmaceuticals' financial data may predict future operating performance. Identifying stable patterns in X4 Pharmaceuticals' historical data and adjusting for structural changes is the first step. These insights directly inform valuation estimates for X4 Pharmaceuticals.
Cash | First Reported 2016-12-31 | Previous Quarter 69.6 M | Current Value 217 M | Quarterly Volatility 43.5 M |
Macro event markers
Naive Prediction Price Forecast For the 27th of March
Given 90 days horizon, the Naive Prediction forecasted value of X4 Pharmaceuticals on the next trading day is expected to be 3.68 with a mean absolute deviation of 0.15 , mean absolute percentage error of 0.04 , and the sum of the absolute errors of 9.16 .Please note that although there have been many attempts to predict XFOR Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that X4 Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Stock Forecast Pattern
| Backtest X4 Pharmaceuticals | X4 Pharmaceuticals Price Prediction | Research Analysis |
Forecasted Value
The next-day forecast for X4 Pharmaceuticals focuses on identifying predictive downside and upside bands that can frame a realistic trading range. The current forecast range spans downside near 0.04 and upside near 8.78.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of X4 Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent X4 Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 116.7892 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.1478 |
| MAPE | Mean absolute percentage error | 0.0393 |
| SAE | Sum of the absolute errors | 9.165 |
Other Forecasting Options for X4 Pharmaceuticals
Relative Strength Index values for XFOR measure the speed and magnitude of recent price changes. Recognizing these clusters in X4 Pharmaceuticals' returns helps calibrate position size and stop-loss levels. Candlestick pattern analysis of XFOR Stock daily data can reveal short-term reversal or continuation signals. Identifying these patterns in XFOR Stock data supports better trade timing.X4 Pharmaceuticals Related Equities
The stocks listed below are peers of X4 Pharmaceuticals within the Health Care space and offer context for ranking and strength. Revenue and margin checks across this group help investors set expectations for X4 Pharmaceuticals' results. Falling behind peers on key ratios may signal headwinds or execution issues worth looking into.
| Risk & Return | Correlation |
X4 Pharmaceuticals Market Strength Events
Market strength indicators provide a structured view of how X4 Pharmaceuticals stock is positioned relative to trends. These indicators are valuable tools for identifying when to enter or exit positions in X4 Pharmaceuticals. These signals help validate or refine position timing for X4 Pharmaceuticals. Review these indicators alongside X4 Pharmaceuticals's fundamental data for a complete analytical picture.
X4 Pharmaceuticals Risk Indicators
The analysis of X4 Pharmaceuticals' risk metrics is one of the most important steps in projecting its future price. This process quantifies the risk associated with X4 Pharmaceuticals' and helps determine how to manage it. A structured analysis of X4 Pharmaceuticals' risk indicators is one of the most reliable ways to improve forecast accuracy. Investors who carefully evaluate the risks in X4 Pharmaceuticals' are better positioned to make informed decisions.
| Mean Deviation | 3.9 | |||
| Semi Deviation | 4.08 | |||
| Standard Deviation | 5.28 | |||
| Variance | 27.83 | |||
| Downside Variance | 19.08 | |||
| Semi Variance | 16.66 | |||
| Expected Short fall | -4.45 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for X4 Pharmaceuticals
Coverage intensity for X4 Pharmaceuticals matters because narrative visibility can influence sentiment, participation, and volatility around the name. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Contributor Headline
Latest Perspective From Macroaxis
X4 Pharmaceuticals Short Properties
Reviewing short-oriented indicators for X4 Pharmaceuticals is useful because long and short participants often create very different signals for timing and volatility. The practical goal is to identify when the balance between long and short participation may be changing the quality of the setup.
| Common Stock Shares Outstanding | 42.3 M | |
| Cash And Short Term Investments | 253 M |
Additional Tools for XFOR Stock Analysis
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |